Your browser doesn't support javascript.
loading
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.
Nowak, Anna K; Lesterhuis, W Joost; Kok, Peey-Sei; Brown, Chris; Hughes, Brett Gm; Karikios, Deme J; John, Thomas; Kao, Steven C-H; Leslie, Connull; Cook, Alistair M; Pavlakis, Nick; Briscoe, Karen; O'Byrne, Kenneth J; Karapetis, Christos S; Lam, Wei-Sen; Langford, Ailsa; Yip, Sonia; Stockler, Martin R.
Afiliação
  • Nowak AK; Sir Charles Gairdner Hospital, Nedlands, WA, Australia; National Centre for Asbestos Related Diseases, Perth, WA, Australia; Medical School, University of Western Australia, Perth, WA, Australia. Electronic address: anna.nowak@uwa.edu.au.
  • Lesterhuis WJ; National Centre for Asbestos Related Diseases, Perth, WA, Australia; School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
  • Kok PS; National Health and Medical Research Council, Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.
  • Brown C; National Health and Medical Research Council, Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.
  • Hughes BG; The Prince Charles Hospital and University of Queensland, Brisbane, QLD, Australia; University of Queensland, Brisbane, QLD, Australia.
  • Karikios DJ; Nepean Hospital, Kingswood, NSW, Australia.
  • John T; Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, VIC, Australia.
  • Kao SC; Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
  • Leslie C; PathWest Laboratory Medicine, Nedlands, WA, Australia.
  • Cook AM; National Centre for Asbestos Related Diseases, Perth, WA, Australia; Medical School, University of Western Australia, Perth, WA, Australia.
  • Pavlakis N; Royal North Shore Hospital and Northern Cancer Institute, Sydney, NSW, Australia.
  • Briscoe K; Mid North Coast Cancer Institute, Coffs Harbour Health Campus, Coffs Harbour, NSW, Australia.
  • O'Byrne KJ; Princess Alexandra Hospital and Queensland University of Technology, Brisbane, QLD, Australia.
  • Karapetis CS; Flinders Medical Centre and Flinders University, Bedford Park, SA, Australia.
  • Lam WS; Department of Medical Oncology, Fiona Stanley Hospital and Western Australia Country Health Service, Perth, WA, Australia.
  • Langford A; National Health and Medical Research Council, Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.
  • Yip S; National Health and Medical Research Council, Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.
  • Stockler MR; National Health and Medical Research Council, Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.
Lancet Oncol ; 21(9): 1213-1223, 2020 09.
Article em En | MEDLINE | ID: mdl-32888453
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Cisplatino / Pemetrexede / Neoplasias Pulmonares / Mesotelioma / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Cisplatino / Pemetrexede / Neoplasias Pulmonares / Mesotelioma / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article